Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.

[1]  T. Munsat,et al.  International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany) , 1992, Neuromuscular Disorders.

[2]  T. Munsat.  International SMA consortium meeting , 1992 .

[3]  J. Osinga,et al.  PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy , 1995, The Lancet.

[4]  J. Weissenbach,et al.  Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.

[5]  T. Crawford,et al.  The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.

[6]  A. Burghes.  When is a deletion not a deletion? When it is converted. , 1997, American journal of human genetics.

[7]  A. Munnich,et al.  The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. , 1997, American journal of human genetics.

[8]  C. Ponting,et al.  Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? , 1997, Human molecular genetics.

[9]  Klaus Zerres,et al.  Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics , 1998, Nature Genetics.

[10]  S. Iannaccone.  Spinal Muscular Atrophy , 1998, Seminars in neurology.

[11]  Li,et al.  [Study of NAIP gene in spinal muscular atrophy] , 1999, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[12]  B. Wirth.  An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA) , 2000, Human mutation.

[13]  G. Dreyfuss,et al.  Characterization of Functional Domains of the SMN Proteinin Vivo * , 2001, The Journal of Biological Chemistry.

[14]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[15]  T. Wienker,et al.  Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.

[16]  P. Bénit,et al.  HUMAN MUTATION 24:417^427 (2004) METHODS Molecular Analysis of SMA Patients Without Homozygous SMN1 Deletions Using a New Strategy for Identification of SMN1 Subtle Mutations , 2022 .

[17]  陈万金,et al.  Correlation between SMN2 copies and the phenotype of spinal muscular atrophy , 2005 .

[18]  N. Darín,et al.  Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy , 2006, Neuromuscular Disorders.

[19]  Wanjin Chen,et al.  Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis. , 2007, Archives of neurology.

[20]  K. Swoboda,et al.  Spinal Muscular Atrophy Genetic Counseling Access and Genetic Knowledge: Parents' Perspectives , 2007, Journal of child neurology.

[21]  E. Aller,et al.  Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene , 2009, Human Genetics.

[22]  N. Darín,et al.  A population‐based study of genotypic and phenotypic variability in children with spinal muscular atrophy , 2009, Acta paediatrica.

[23]  C. Beattie,et al.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? , 2009, Nature Reviews Neuroscience.

[24]  Liang Li,et al.  Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population , 2010, European Journal of Human Genetics.

[25]  J. Kissel,et al.  Spinal muscular atrophy: a timely review. , 2011, Archives of neurology.

[26]  T. Prior,et al.  Technical standards and guidelines for spinal muscular atrophy testing , 2011, Genetics in Medicine.

[27]  V. Gatta,et al.  Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases , 2012, International journal of molecular sciences.

[28]  M. Gribaa,et al.  Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.